Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prohormone atrial natriuretic peptides 1-30 and 31-67 increase in hyperthyroidism and decrease in hypothyroidism.

D L Vesely1, C J Winters, A L Sallman

  • 1Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock.

The American Journal of the Medical Sciences
|April 1, 1989
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice.

European journal of clinical investigation·2010
Same author

Cardiac hormones activate ERK 1/2 kinases in human fibroblasts.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008
Same author

Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice.

European journal of clinical investigation·2008
Same author

Phosphatidylinositol 3-kinase/Akt signaling mediates interleukin-6 protection against p53-induced apoptosis in M1 myeloid leukemic cells.

Oncogene·2006
Same author

Urodilatin and four cardiac hormones decrease human renal carcinoma cell numbers.

European journal of clinical investigation·2006
Same author

Circadian distribution of hematology variables in subjects with multiple sclerosis.

La Clinica terapeutica·2006

Thyroid hormones significantly impact atrial natriuretic factor (ANF) levels. Hyperthyroidism elevates proANF peptides, while hypothyroidism decreases them, with levels normalizing after treatment.

Area of Science:

  • Endocrinology
  • Cardiovascular Physiology
  • Hormone Research

Background:

  • Hyperthyroidism is linked to natriuresis and vasodilation.
  • Hypothyroidism is associated with impaired water excretion and vasoconstriction.
  • Atrial natriuretic factor (ANF) plays a role in fluid and electrolyte balance.

Purpose of the Study:

  • To investigate plasma concentrations of three prohormone atrial natriuretic peptides (pro ANFs) in hyperthyroid and hypothyroid patients.
  • To compare these levels to those in healthy individuals.
  • To assess the effect of treatment and L-thyroxine dosage on proANF levels.

Main Methods:

  • Measurement of plasma concentrations of proANFs 1-30, 31-67, and ANF (99-126).
  • Comparison of levels between hyperthyroid patients, hypothyroid patients, and 54 healthy controls.

Related Experiment Videos

  • Monitoring of peptide levels after treatment and with varying L-thyroxine dosages.

    • Main Results:

    • ProANFs 1-30, 31-67, and ANF were significantly elevated in hyperthyroid patients (3x, 4x, 2x respectively) compared to controls.
    • Hypothyroid patients showed reduced levels (0.5x) of the three peptides.
    • Treatment normalized peptide levels in both hyperthyroid and hypothyroid patients.
    • In hypothyroid patients with congestive heart failure, proANF levels were elevated, indicating a strong stimulus from salt and water metabolism abnormalities.

    Conclusions:

    • Plasma concentrations of prohormone atrial natriuretic peptides are significantly altered in thyroid dysfunction.
    • Thyroid status directly influences the circulating levels of these cardiac hormones.
    • Abnormalities in salt and water metabolism, as seen in congestive heart failure complicating hypothyroidism, strongly stimulate proANF release.